Viking Therapeutics, Inc. (LON:0VQA)
27.16
-0.47 (-1.71%)
At close: May 23, 2025
Viking Therapeutics Employees
Viking Therapeutics had 36 employees as of December 31, 2024. The number of employees increased by 9 or 33.33% compared to the previous year.
Employees
36
Change (1Y)
9
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-2.16M GBP
Market Cap
2.25B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Viking Therapeutics News
- 18 days ago - Why Viking Therapeutics Stock Surged Nearly 20% Higher in April - The Motley Fool
- 20 days ago - Viking Therapeutics (VKTX) Sees 20% Stock Surge Despite Financial Losses - GuruFocus
- 22 days ago - Why Viking Therapeutics Stock Was Victorious This Week - The Motley Fool
- 22 days ago - Where Will Viking Therapeutics Be in 3 Years? - The Motley Fool
- 24 days ago - Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? - The Motley Fool
- 4 weeks ago - Decoding Viking Therapeutics Inc (VKTX): A Strategic SWOT Insight - GuruFocus
- 4 weeks ago - Viking Therapeutics: Q1 Earnings Overview - Hard To Understand Wall Street's Pessimism - Seeking Alpha
- 4 weeks ago - Viking Therapeutics targets 2025 Phase 3 trials for VK2735 obesity program with promising results - Seeking Alpha